At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy

Clinical Review for Basic Researchers: Treating patients with CTLA‐4 and PD‐1 pathway blocking antibodies, plus clinical progress and application of agents in earlier stages of development. It is increasingly appreciated that cancers are recognized by the immune system, and under some circumstances,...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of leukocyte biology Vol. 94; no. 1; pp. 41 - 53
Main Authors:	Callahan, Margaret K., Wolchok, Jedd D.
Format:	Journal Article
Language:	English
Published:	United States Society for Leukocyte Biology 01.07.2013
Subjects:	Antibodies, Blocking - therapeutic use Clinical Trials as Topic CTLA-4 Antigen - antagonists & inhibitors CTLA-4 Antigen - immunology endpoints Humans Immunotherapy Neoplasms - immunology Neoplasms - therapy overall survival Paired Basic-Translational Reviews Programmed Cell Death 1 Receptor - antagonists & inhibitors Programmed Cell Death 1 Receptor - immunology tumor overall survival endpoints tumor
ISSN:	0741-5400, 1938-3673, 1938-3673
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!